Lucid Diagnostics Inc. (NASDAQ: LUCD) shares pick up new ground Wednesday, on word of a recent company achievement. The commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (NASDAQ:PAVM) today announced that the 4,000th firefighter has undergone esophageal precancer testing using Lucid's EsoGuard® Esophageal DNA test as part of a #CheckYourFoodTube Precancer Testing Event. In partnership with physicians from Mass General Brigham, Boston'sLocal 718 International Association of Fire Fighters (IAFF) hosted its first #CheckYourFoodTube event to ensure its at-risk firefighters could be tested for esophageal precancer.
This milestone coincided with Esophageal Cancer Awareness Month and highlighted the proactive steps being taken by the broader firefighter community to address the elevated risk of cancer in firefighters.
"Early detection and preventative screenings are paramount in ensuring the health and safety of everyone, but especially firefighters," said Sam Dillon, Boston Firefighters Local 718 IAFF President. "There is a startling number of firefighters being diagnosed with and dying from esophageal cancer, and the EsoGuard test from Lucid Diagnostics is able to detect precancer signals and allow firefighters like me to go through treatment before actually developing cancer. I strongly encourage all firefighters to take advantage of the #CheckYourFoodTube esophageal precancer screening events, as I did."
LUCD shares gathered seven cents, or 2.4%, to $2.72, while those for PAVM took on two cents, or 1.7%, to $1.18.
